Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

731081

	registered interest
	date	21/06/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how many NHS staff members are from (1) EU member states other than the UK, and (2) countries outside the EU.
	tabling member printed	Lord Roberts of Llandudno
	uin	HL89
	answer	answer is ministerial correction date of answer 04/07/2017 answer text <p>NHS Digital publishes data on the nationality of staff working in the National Health Service in England. Nationality is self-reported within the NHS human resources and payroll system, the electronic staff record.</p><p>As of 31 March 2017, latest data available, there are now 61,934 (headcount) European Union nationals (excluding the United Kingdom), or 5.2% employed in the NHS trusts and clinical commissioning groups. There are 75,450 other overseas nationals, or 6.4% employed in the NHS. 80,822 NHS staff records do not contain nationality data, with people either choosing not to specify their nationality or not asked to.</p> answering member printed Lord O'Shaughnessy question first answered 04/07/2017 15:50:03 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3691 label Biography information for Lord Roberts of Llandudno

804237

	registered interest
	date	11/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Professions: Training
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how they plan to train additional medical staff from the UK to replace existing staff from other EU countries who have left or might leave the NHS.
	tabling member printed	Lord Roberts of Llandudno
	uin	HL4058
	answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>In October 2016, the Government announced a historic expansion of medical school places increasing medical school places in England by 1,500. The first 500 places have already been allocated and will be available to students in September 2018. The remaining 1,000 additional medical school places would be available to medical schools in England via a competitive bidding process managed jointly by the Higher Education Funding Council for England and Health Education England.</p><p> </p><p>We have also announced a 25% increase in nurse training places to provide at least 5,000 extra nurse training places every year from 2018/19 - 25,850 from 2018/19 compared to 20,680 in 2016/17.</p><p> </p><p>National Health Service workforce training in Northern Ireland, Scotland and Wales are matters for the devolved administrations in each of those countries.</p> answering member printed Lord O'Shaughnessy question first answered 22/12/2017 12:44:31 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3691 label Biography information for Lord Roberts of Llandudno

930930

	registered interest
	date	25/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medicine: Research
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how they will protect joint projects with EU member states into disabilities and diseases if the UK leaves the EU.
	tabling member printed	Lord Roberts of Llandudno
	uin	HL8930
	answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>We want to continue to cooperate closely with our European partners to the benefit of all citizens and patients in the United Kingdom and across the European Union. As part of this, we are determined to continue working closely with health ministers across the EU and the European Commission and Parliament on a wide variety of issues including disabilities and diseases. Whilst we cannot pre-empt the negotiations, nor can we disadvantage the UK’s position in these negotiations by giving inappropriate guarantees at this time, the Government will continue to seek the best possible deal for the UK.</p> answering member printed Lord O'Shaughnessy question first answered 09/07/2018 10:43:10 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3691 label Biography information for Lord Roberts of Llandudno

768561

	registered interest
	date	11/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: Foreign Nationals
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the extent to which the changes brought in by National Health Service (Charges to Overseas Visitors) (Amendment) Regulations 2017 may exacerbate health inequalities; whether they have made any further estimate of the savings to be made since publishing their impact assessment; if so, what is the difference between those two estimates; and whether they plan to reconsider those changes.
	tabling member printed	Lord Roberts of Llandudno
	uin	HL1911
	answer	answer is ministerial correction date of answer 18/10/2017 answer text <p>Following a detailed public consultation that ran from December 2015 to March 2016, the Government set out in its response to that consultation in February 2017 that it intended to amend the existing Charging Regulations. Over the course of the consultation and decision-making process, the Government carefully considered the impact the changes may have on public health, health inequalities and on vulnerable groups. The regulations providing for these changes were introduced on 19 July 2017 alongside a published impact assessment which estimated that the net income per annum as a result of the new regulations would be up to £40 million per year. While the Government monitors the implementation of the regulations and their effects, no further estimates on the net income have been made since the publication of the impact assessment.</p> answering member printed Lord O'Shaughnessy question first answered 18/10/2017 09:36:33 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3691 label Biography information for Lord Roberts of Llandudno

850572

	registered interest
	date	27/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of why flash glucose monitors are available to patients in some parts of England and not in others.
	tabling member printed	Lord Roberts of Llandudno
	uin	HL5916
	answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>Freestyle Libre, the flash glucose monitoring system was included in Part IX of the England and Wales Drug Tariff from November 2017. People with diabetes insipidus or diabetes mellitus (except where treatment is by diet alone) - which includes type 1 and type 2 diabetes - are eligible for free National Health Service prescriptions if they hold a valid medical exemption certificate. However, patients will need to discuss the ongoing management of their condition with their healthcare professional and consider what is most suitable for them.</p><p>Within its financial constraints, the NHS is committed to providing access to new drugs and medical technologies. Ultimately it is for clinical commissioning groups (CCGs), who are primarily responsible for commissioning diabetes services, to meet the requirements of their population. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population and are based on the available evidence and take into account national guidelines.</p><p>Reducing variation in the management and care of people with diabetes by 2020 is an objective included in the NHS England mandate. The NHS RightCare diabetes pathway shows the core components of an optimal diabetes service, as well as evidence of the opportunity to reduce variation. People with diabetes insipidus or diabetes mellitus (except where treatment is by diet alone) - which includes type 1 and type 2 diabetes - are eligible for free NHS prescriptions if they hold a valid medical exemption certificate.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL5914 HL5915 question first answered 13/03/2018 15:47:25 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3691 label Biography information for Lord Roberts of Llandudno

908918

	registered interest
	date	21/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what measures are in place to ensure equitable access to (1) insulin pumps, and (2) other diabetes technologies, across England.
	tabling member printed	Lord Roberts of Llandudno
	uin	HL8080
	answer	answer is ministerial correction date of answer 05/06/2018 answer text <p>Clinical commissioning groups (CCGs) are responsible for commissioning diabetes services to meet the requirements of their population. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population and are based on the available evidence and take into account national guidelines. This should include consideration of access to insulin pumps and other diabetes technologies for people with diabetes who might benefit from them.</p> answering member printed Lord O'Shaughnessy question first answered 05/06/2018 15:55:33 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3691 label Biography information for Lord Roberts of Llandudno

874611

	registered interest
	date	29/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have for the long-term approach to diabetes.
	tabling member printed	Lord Roberts of Llandudno
	uin	HL6831
	answer	answer is ministerial correction date of answer 16/04/2018 answer text <p>The long-term approach to diabetes involves both seeking to reduce the increase in the prevalence of diabetes and, for those with diabetes, seeking to reduce the likelihood of developing complications and improving overall levels of treatment and care.</p><p>Work to reduce the increase in future prevalence of type 2 diabetes is being delivered through the NHS Diabetes Prevention Programme. By 2020, the programme will support up to 100,000 people at high risk of type 2 diabetes each year across England. Those referred will get tailored, personalised support over at least nine months to achieve a healthy weight, improve nutrition and increase levels of physical activity in order to reduce risks of developing type 2 diabetes.</p><p>Work on reducing the likelihood of those with diabetes developing complications is through the diabetes treatment and care programme. This focuses on four key interventions:</p><p>- Increasing attendance at structured education by both those newly diagnosed with diabetes and those who have had the condition for a longer period;</p><p>- Increasing achievement of the diabetes treatment targets and reducing variation in achievement of these targets between clinical commissioning groups and between general practitioner practices;</p><p>- Reducing the levels of amputations by increasing the availability of multidisciplinary footcare teams; and</p><p>- Reducing lengths of inpatient stay for people with diabetes by increasing the availability of diabetes inpatient specialist nurses.</p><p> </p> answering member printed Lord O'Shaughnessy question first answered 16/04/2018 14:02:32 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3691 label Biography information for Lord Roberts of Llandudno

850571

	registered interest
	date	27/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps they are taking to ensure that all Clinical Commissioning Groups are adequately funded to supply flash glucose monitors to all patients with type 1 diabetes.
	tabling member printed	Lord Roberts of Llandudno
	uin	HL5915
	answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>Freestyle Libre, the flash glucose monitoring system was included in Part IX of the England and Wales Drug Tariff from November 2017. People with diabetes insipidus or diabetes mellitus (except where treatment is by diet alone) - which includes type 1 and type 2 diabetes - are eligible for free National Health Service prescriptions if they hold a valid medical exemption certificate. However, patients will need to discuss the ongoing management of their condition with their healthcare professional and consider what is most suitable for them.</p><p>Within its financial constraints, the NHS is committed to providing access to new drugs and medical technologies. Ultimately it is for clinical commissioning groups (CCGs), who are primarily responsible for commissioning diabetes services, to meet the requirements of their population. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population and are based on the available evidence and take into account national guidelines.</p><p>Reducing variation in the management and care of people with diabetes by 2020 is an objective included in the NHS England mandate. The NHS RightCare diabetes pathway shows the core components of an optimal diabetes service, as well as evidence of the opportunity to reduce variation. People with diabetes insipidus or diabetes mellitus (except where treatment is by diet alone) - which includes type 1 and type 2 diabetes - are eligible for free NHS prescriptions if they hold a valid medical exemption certificate.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL5914 HL5916 question first answered 13/03/2018 15:47:25 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3691 label Biography information for Lord Roberts of Llandudno

850570

	registered interest
	date	27/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps they are taking to ensure that all patients with type 1 diabetes in England have access to flash glucose monitors.
	tabling member printed	Lord Roberts of Llandudno
	uin	HL5914
	answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>Freestyle Libre, the flash glucose monitoring system was included in Part IX of the England and Wales Drug Tariff from November 2017. People with diabetes insipidus or diabetes mellitus (except where treatment is by diet alone) - which includes type 1 and type 2 diabetes - are eligible for free National Health Service prescriptions if they hold a valid medical exemption certificate. However, patients will need to discuss the ongoing management of their condition with their healthcare professional and consider what is most suitable for them.</p><p>Within its financial constraints, the NHS is committed to providing access to new drugs and medical technologies. Ultimately it is for clinical commissioning groups (CCGs), who are primarily responsible for commissioning diabetes services, to meet the requirements of their population. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population and are based on the available evidence and take into account national guidelines.</p><p>Reducing variation in the management and care of people with diabetes by 2020 is an objective included in the NHS England mandate. The NHS RightCare diabetes pathway shows the core components of an optimal diabetes service, as well as evidence of the opportunity to reduce variation. People with diabetes insipidus or diabetes mellitus (except where treatment is by diet alone) - which includes type 1 and type 2 diabetes - are eligible for free NHS prescriptions if they hold a valid medical exemption certificate.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL5915 HL5916 question first answered 13/03/2018 15:47:24 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3691 label Biography information for Lord Roberts of Llandudno

873034

	registered interest
	date	27/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments: Innovation
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps they are taking to ensure that the benefits of medical advances are available on the NHS in all areas of England.
	tabling member printed	Lord Roberts of Llandudno
	uin	HL6714
	answer	answer is ministerial correction date of answer 09/04/2018 answer text <p>From April 2018 we are introducing a new Accelerated Access Pathway to streamline regulatory and market access decisions, getting products that we believe will be truly transformative to patients more quickly. The Pathway will be delivered by the Accelerated Access Collaborative, who will help unlock system barriers and disseminate learning. The Government is also working with key partners to expand the National Health Service Innovation Scorecard so that it covers a greater range of innovative products and is used more widely to identify unwarranted variation in uptake and improve patient outcomes.</p><p>In addition to this, we have also provided £39 million to improve local adoption and uptake of innovative medical technologies through the 15 Academic Health and Science Networks (AHSNs). The AHSNs will provide a ‘front door’ for innovators to access the support that they need and increase local knowledge sharing. Finally, the Government will help the NHS to adopt and integrate new technologies into everyday practice through the £6 million Pathway Transformation Fund.</p> answering member printed Lord O'Shaughnessy question first answered 09/04/2018 13:50:49 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3691 label Biography information for Lord Roberts of Llandudno